Pharma firm Abbott India today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.
The company had posted a net profit of Rs 61.16 crore in the year-ago period, Abbott India said in a BSE filing.
Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.
Abbott India offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.
Shares of Abbott India today closed 4.88 per cent higher at Rs 4,925 apiece on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)